Status:
COMPLETED
Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION)
Lead Sponsor:
Igenomix
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
In late December 2019, a new coronavirus strain emerged in China causing coronavirus disease 2019 (COVID-19). Since then, COVID-19 has become a global pandemic outbreak being declared a "public health...
Detailed Description
In late December 2019, a new coronavirus strain emerged in Chinese megacity Wuhan. The World Health Organization (WHO) named it Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) leading to c...
Eligibility Criteria
Inclusion
- Mainly asymptomatic individuals from different corporations of urban areas of Barcelona, Madrid and Valencia that have performed the test before initiating the work immediately after Spanish lockdown from the end of April until beginning of May.
Exclusion
- There is not exclusion criteria for this study.
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 25 2020
Estimated Enrollment :
1526 Patients enrolled
Trial Details
Trial ID
NCT04389658
Start Date
May 7 2020
End Date
August 25 2020
Last Update
October 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Igenomix
Paterna, Valencia, Spain, 46980